Search results - 5 results

COVID-19 vaccine prioritisation for people with cystic fibrosis.

Luiz Vicente R F da Silva; Stephenson, Anne L; Cheng, Stephanie Y; Melo, Joel; Corvol, Harriet; Burgel, Pierre-Régis; Nährlich, Lutz; McKone, Edward; Colombo, Carla; Salvatore, Marco; Padoan, Rita; ...

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Nährlich; Kashirskaya, Nataliya; Marshall, Bruce C; McKone, Edward; Middleton, Peter G; Mondejar-Lopez, Pedro; Pastor-Vivero, M Dolores; Padoan, Rita; Rizvi, Samar; Ruseckaite, Rasa; Salvatore, Marco; ...

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

Publication Type: Peer reviewed scientific article Authors: Cosgriff, Rebecca; Ahern, Susannah; Bell, Scott C.; Brownlee, Keith; Burgel, Pierre-Régis; Byrnes, Cass; Corvol, Harriet; Cheng, Stephanie ...

Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.

aeruginosa (Pa), were explored. METHODS: We performed a retrospective case-control study in 73 Pa-negative patients. Each patient was matched with 2 controls for age, gender, pancreas sufficiency, DeltaF508 ...

Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.

subjects contributed data with 2,976 data pairs analysed, 44.9% concerning years of ICS use. Yearly % predicted decline in forced expiratory volume in 1 s (FEV ₁) was 1.07% lower during ICS use (p = 0.001). ...

QR code

QR code for this page URL